PAI-1 and atherothrombosis. [J Thromb Haemost. 2005]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 1

Click to change filter selection through MyNCBI.

1: J Thromb Haemost. 2005 Aug;3(8):1879-83. Links

PAI-1 and atherothrombosis.

Vaughan DE.

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA. doug.vaughan@vanderbilt.edu

Plasminogen activator inhibitor-1 (PAI-1) is the major physiologic inhibitor of tissue-type plasminogen activator in plasma, and is elevated in a variety of clinical situations that are associated with increased risk of ischemic cardiovascular events. Recent insights into the biology of PAI-1 suggest that it is more than just an innocent bystander in the pathogenesis of ischemic heart disease. Elevated PAI-1 levels appear to increase the risk of atherothrombotic events and may also promote the progression of vascular disease. The development and testing of specific PAI-1 antagonists will enable basic and clinical investigators the opportunity to test the hypothesis that vascular PAI-1 excess promotes the development of intravascular thrombosis and atherosclerosis.

PMID: 16102055 [PubMed - indexed for MEDLINE]

ReviewPlasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis.
Front Biosci. 2007 May 1; 12:2957-66. Epub 2007 May 1.

[Front Biosci. 2007]
ReviewPAI-1, obesity, insulin resistance and risk of cardiovascular events.
Thromb Haemost. 1997 Jul; 78(1):656-60.

[Thromb Haemost. 1997]
ReviewHypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Ann Med. 2000 Dec; 32 Suppl 1:78-84.

[Ann Med. 2000]
ReviewPlasma plasminogen activator inhibitor 1, insulin resistance and android obesity.
Biomed Pharmacother. 1999 Dec; 53(10):455-61.

[Biomed Pharmacother. 1999]
ReviewPlasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Curr Opin Lipidol. 2007 Jun; 18(3):240-5.

[Curr Opin Lipidol. 2007]
» See reviews... | » See all...

Cited by 9 PubMed Central articles

Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.
An WS, Kim SE, Kim KH, Bae HR, Rha SH. J Korean Med Sci. 2009 Jan; 24 Suppl:S115-20. Epub 2009 Jan 28.

[J Korean Med Sci. 2009]
Toxicogenomic analysis of mainstream tobacco smoke-exposed mice reveals repression of plasminogen activator inhibitor-1 gene in heart.
Halappanavar S, Stampfli MR, Berndt-Weis L, Williams A, Douglas GR, Yauk CL. Inhal Toxicol. 2009 Jan; 21(1):78-85.

[Inhal Toxicol. 2009]
ReviewFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.
Ban CR, Twigg SM. Vasc Health Risk Manag. 2008; 4(3):575-96.

[Vasc Health Risk Manag. 2008]
» See all...

Recent Activity

Clear Turn Off Turn On

PAI-1 and atherothrombosis.PAI-1 and atherothrombosis.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

PAI-1 and atherothrombosis.

Related articles

Cited by 9 PubMed Central articles

Recent Activity